Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia

L. R. Martins, P. Lúcio, A. Melão, I. Antunes, B. A. Cardoso, R. Stansfield, M. T S Bertilaccio, P. Ghia, D. Drygin, M. G. Silva, J. T. Barata

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)179-182
Number of pages4
JournalLeukemia
Volume28
Issue number1
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Martins, L. R., Lúcio, P., Melão, A., Antunes, I., Cardoso, B. A., Stansfield, R., Bertilaccio, M. T. S., Ghia, P., Drygin, D., Silva, M. G., & Barata, J. T. (2014). Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia. Leukemia, 28(1), 179-182. https://doi.org/10.1038/leu.2013.232